ALZHEON, INC. — Form D/A

ALZHEON, INC. of FRAMINGHAM, MA, a company, filed a Form D amendment with the SEC on 2018-09-05. The offering totals $19.8M, of which $19.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Jean-Pierre GarnierDirectorFramingham, MA
Franz HeftiDirectorSan Diego, CA
Dennis LangerDirectorNaples, FL
Scott MinickDirectorSunnyvale, CA
David NikodemDirectorSan Diego, CA
Martin TolarDirectorFramingham, MA
Martin TolarExecutive OfficerFramingham, MA
Menghis BairuDirectorSan Mateo, CA
Michael AcetiExecutive OfficerNeedham, MA
Diane K Jorkasky, M.D.DirectorFramingham, MA
Muneer E SatterDirectorFramingham, MA
Neil W FlanzraichDirectorFramingham, MA
Glenn E PaulyExecutive OfficerFramingham, MA
Susan K Abushakra, M.D.Executive OfficerFramingham, MA
John K Hey, Ph.D.Executive OfficerFramingham, MA
Kenneth A MaceExecutive OfficerFramingham, MA
Martin Tolar, M.D., Ph.D.DirectorFramingham, MA
Martin Tolar, M.D., Ph.D.Executive OfficerFramingham, MA
Gino K SantiniDirectorFramingham, MA
Christopher Noel DunnDirectorVancouver, A1
Adem E AlbayrakExecutive OfficerFramingham, MA
Jordan W HellerDirectorFramingham, MA
Aidan K Power, MRCPsychExecutive OfficerFramingham, MA
Muneer E SateerDirectorFramingham, MA
Robert SilvermanExecutive OfficerGreenville, SC

Other filings by this issuer (13)

FiledFormOfferingSold
2025-02-10D/A$150.0M$126.3M
2025-01-02D/A$125.0M$125.0M
2024-03-12D$50.0M$17.2M
2023-01-11D$50.0M$1.7M
2020-09-30D$50.0M$2.4M
2020-01-15D$6.2M$6.2M
2017-06-09D$15.8M$15.8M
2016-02-26D$5.0M$1.3M
2015-07-27D$6.9M$6.9M
2015-02-25D/A$7.3M
2015-01-09D$3.0M
2013-12-16D/A$550K$550K
2013-07-31D$550K$330K

More